{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661v1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10106","date":"2024-09-30T20:20:45.681Z","role":"Publisher"},{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10106","date":"2024-09-30T16:00:00.000Z","role":"Approver"}],"curationReasons":{"id":"cg:NewCuration"},"earliestArticle":{"id":"https://pubmed.ncbi.nlm.nih.gov/20089971","type":"dc:BibliographicResource","dc:abstract":"Establishing the genetic basis of phenotypes such as skeletal dysplasia in model organisms can provide insights into biologic processes and their role in human disease.","dc:creator":"Smits P","dc:date":"2010","dc:title":"Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210."},"evidence":[{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:38e9f858-966c-44c9-995f-371b990cf47c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:5c883a63-46bb-4e61-ad00-0d3915d137a6","type":"Finding","demonstrates":{"id":"cg:GeneExpressionB"},"dc:description":"No protein produced in 2 patients with Achondrogenesis type 1A and reduced amounts and no full length protein in 3 patients with Odontochondrodysplasia where each patient has a variant that has been shown to result in missplicing with in-frame deletions.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/30728324","type":"dc:BibliographicResource","dc:abstract":"Odontochondrodysplasia (ODCD) is an unresolved genetic disorder of skeletal and dental development. Here, we show that ODCD is caused by hypomorphic TRIP11 mutations, and we identify ODCD as the nonlethal counterpart to achondrogenesis 1A (ACG1A), the known null phenotype in humans. TRIP11 encodes Golgi-associated microtubule-binding protein 210 (GMAP-210), an essential tether protein of the Golgi apparatus that physically interacts with intraflagellar transport 20 (IFT20), a component of the ciliary intraflagellar transport complex B. This association and extraskeletal disease manifestations in ODCD point to a cilium-dependent pathogenesis. However, our functional studies in patient-derived primary cells clearly support a Golgi-based disease mechanism. In spite of reduced abundance, residual GMAP variants maintain partial Golgi integrity, normal global protein secretion, and subcellular distribution of IFT20 in ODCD. These functions are lost when GMAP-210 is completely abrogated in ACG1A. However, a similar defect in chondrocyte maturation is observed in both disorders, which produces a cellular achondrogenesis phenotype of different severity, ensuing from aberrant glycan processing and impaired extracellular matrix proteoglycan secretion by the Golgi apparatus.","dc:creator":"Wehrle A","dc:date":"2019","dc:title":"Hypomorphic mutations of TRIP11 cause odontochondrodysplasia."},"rdfs:label":"RNA analysis in chondrocytes and Western blotting"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:31a7f8e4-5caa-45f4-b798-5ada69bbc0ec","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:0167c3fe-d7ec-4c84-b327-620a8a05ac0b","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Phenotype in mice is extremely similar to that observed in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20089971","rdfs:label":"Mouse model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:3bf2b569-f81a-4ad9-9126-79d16f7f7ea2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:3bf2b569-f81a-4ad9-9126-79d16f7f7ea2","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":30,"allele":[{"id":"cggv:7ce67852-383a-4863-a2f1-98e392e8236b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.4534C>T (p.Gln1512Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7313440"}},{"id":"cggv:9a6c7dce-7d9e-4d0d-a1a5-55b4209cc247","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.586C>T (p.Gln196Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7314156"}}],"phenotypes":["obo:HP_0002657","obo:HP_0003027","obo:HP_0000774","obo:HP_0001156","obo:HP_0000256","obo:HP_0000703","obo:HP_0004322","obo:HP_0002650"],"previousTesting":true,"previousTestingDescription":"Sanger testing of COMP & RMRP genes","sex":"Female","variant":[{"id":"cggv:154d1d75-7a20-40fa-b5c7-434285217c98_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9a6c7dce-7d9e-4d0d-a1a5-55b4209cc247"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"},{"id":"cggv:fe759b8c-82ae-406a-a0cf-fc94b6ce3e86_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:7ce67852-383a-4863-a2f1-98e392e8236b"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"}],"rdfs:label":"Wehrle 2019 Case4"},{"id":"cggv:154d1d75-7a20-40fa-b5c7-434285217c98","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:154d1d75-7a20-40fa-b5c7-434285217c98_variant_evidence_item"},{"id":"cggv:154d1d75-7a20-40fa-b5c7-434285217c98_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Splice studies, Western blot, immunohistochemistry"}],"strengthScore":0.5,"dc:description":"Splice studies shows variant escapes NMD and leads to missplicing so reduced default to 0.1, functional studies increase to 0.5"},{"id":"cggv:fe759b8c-82ae-406a-a0cf-fc94b6ce3e86","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:fe759b8c-82ae-406a-a0cf-fc94b6ce3e86_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:b02d59d9-8be4-45fe-8b9d-74696210079e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:b02d59d9-8be4-45fe-8b9d-74696210079e","type":"Proband","ageType":"AgeAtDeath","ageUnit":"WeeksGestation","ageValue":20,"allele":{"id":"cggv:47922af1-9177-4aac-8560-bda3535c96de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.757C>T (p.Arg253Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2635180"}},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0200083","obo:HP_0010306","obo:HP_0000773","obo:HP_0010675","obo:HP_0010660","obo:HP_0004606","obo:HP_0003826"],"previousTesting":false,"sex":"Male","variant":{"id":"cggv:444575fe-3caa-4f0f-a4bb-18b78d400134_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:47922af1-9177-4aac-8560-bda3535c96de"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/23956106","type":"dc:BibliographicResource","dc:abstract":"Achondrogenesis 1A (ACG1A; OMIM 200600) is an autosomal recessive perinatally lethal skeletal dysplasia comprising intrauterine growth failure, micromelia, minor facial anomalies, deficient ossification of the skull, absent or extremely defective spinal ossification, short beaded ribs, and short deformed long bones with a stellate appearance. ACG1A is caused by mutations in the TRIP11 gene, resulting in deficiency of the Golgi microtubule associated protein 210. In this study we describe dizygotic twins with a clinical and radiological phenotype of ACG1A who were homozygous for a novel nonsense mutation in the TRIP11 gene. In addition, another patient with a milder manifestation, not readily distinguishable from those of other lethal skeletal dysplasias, was found to be a compound heterozygote for a nonsense mutation and a deletion of the 3' end of the TRIP11 gene. We conclude that mutations of the TRIP11 gene may encompass a wider phenotypic range than previously recognized.","dc:creator":"Grigelioniene G","dc:date":"2013","dc:title":"The phenotype range of achondrogenesis 1A."}},"rdfs:label":"Grigelioniene 2013 case3"},{"id":"cggv:444575fe-3caa-4f0f-a4bb-18b78d400134","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:444575fe-3caa-4f0f-a4bb-18b78d400134_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:69099054-8c2e-45c7-bd77-842de58b4c9a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:69099054-8c2e-45c7-bd77-842de58b4c9a","type":"Proband","ageType":"AgeAtDeath","ageUnit":"WeeksGestation","ageValue":28,"allele":{"id":"cggv:c19a63f1-555b-4bab-9bf5-e5e32052ece9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.2304_2307del (p.Asn768LysfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA616112949"}},"ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003270","obo:HP_0002983","obo:HP_0000774","obo:HP_0000474","obo:HP_0003196","obo:HP_0003510","obo:HP_0000470","obo:HP_0000262"],"sex":"Male","variant":{"id":"cggv:6bd86ce0-a1a6-4a4a-970a-1597f0c672a5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c19a63f1-555b-4bab-9bf5-e5e32052ece9"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29872333","type":"dc:BibliographicResource","dc:abstract":"Achondrogenesis type IA (ACG1A) is a rare, lethal autosomal recessive chondrodysplasia affecting endochondral bone ossification and differentiation, causing intrauterine growth restriction, narrow thorax, and short limbs. Mutations in ","dc:creator":"Vanegas S","dc:date":"2018","dc:title":"Achondrogenesis type 1A: clinical, histologic, molecular, and prenatal ultrasound diagnosis."}},"rdfs:label":"Vanegas 2018 Case1"},{"id":"cggv:6bd86ce0-a1a6-4a4a-970a-1597f0c672a5","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:6bd86ce0-a1a6-4a4a-970a-1597f0c672a5_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:d90d9bfc-1645-4595-bec5-f150ca8aea9e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:d90d9bfc-1645-4595-bec5-f150ca8aea9e","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":16,"allele":[{"id":"cggv:9a6c7dce-7d9e-4d0d-a1a5-55b4209cc247"},{"id":"cggv:03b0cc7e-8483-40aa-a6c7-2de7edb4c9a4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.2993_2994del (p.Lys998SerfsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190649"}}],"phenotypes":["obo:HP_0001156","obo:HP_0000256","obo:HP_0002650","obo:HP_0003027","obo:HP_0002657","obo:HP_0000703","obo:HP_0000768","obo:HP_0000774","obo:HP_0002205","obo:HP_0004322"],"sex":"Female","variant":[{"id":"cggv:670812ac-6a9d-4e89-bd84-3dd031327a6e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9a6c7dce-7d9e-4d0d-a1a5-55b4209cc247"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"},{"id":"cggv:f13c1cf8-9aee-4fc9-b566-a18c7d16be89_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:03b0cc7e-8483-40aa-a6c7-2de7edb4c9a4"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"}],"rdfs:label":"Wehrle 2019 Case7"},{"id":"cggv:670812ac-6a9d-4e89-bd84-3dd031327a6e","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:670812ac-6a9d-4e89-bd84-3dd031327a6e_variant_evidence_item"},{"id":"cggv:670812ac-6a9d-4e89-bd84-3dd031327a6e_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Splice studies confirm variant affects splicing leading to inframe deletion and can escape NMD. Western blotting and immunohistochemistry experiments support pathogenicity."}],"strengthScore":0.5,"dc:description":"Splice studies confirm variant affects splicing leading to inframe deletion and can escape NMD so reduced default to 0.1 and then the variant has functional data so increased to 0.5."},{"id":"cggv:f13c1cf8-9aee-4fc9-b566-a18c7d16be89","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:f13c1cf8-9aee-4fc9-b566-a18c7d16be89_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ff202892-8781-4fdd-b297-f7e1c6f18234_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ff202892-8781-4fdd-b297-f7e1c6f18234","type":"Proband","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":3,"allele":[{"id":"cggv:9a6c7dce-7d9e-4d0d-a1a5-55b4209cc247"},{"id":"cggv:0c45cd9e-576f-4e6f-b04c-4ff399684dbd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.790C>T (p.Arg264Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA117560"}}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0003027","obo:HP_0000774","obo:HP_0002089","obo:HP_0001156","obo:HP_0000256","obo:HP_0002657","obo:HP_0004322"],"sex":"Male","variant":[{"id":"cggv:65b3c9c3-aaf5-4fd3-bd5c-af8f39da1abb_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0c45cd9e-576f-4e6f-b04c-4ff399684dbd"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"},{"id":"cggv:f7680fa6-f297-4d88-b736-28639f468613_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9a6c7dce-7d9e-4d0d-a1a5-55b4209cc247"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"}],"rdfs:label":"Wehrle 2019 Case8"},{"id":"cggv:f7680fa6-f297-4d88-b736-28639f468613","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:f7680fa6-f297-4d88-b736-28639f468613_variant_evidence_item"},{"id":"cggv:f7680fa6-f297-4d88-b736-28639f468613_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Splice studies show that this variant leads to an in frame deletion and escapes NMD. Western blotting and immunohistochemistry results provide evidence of pathogenicity."}],"strengthScore":0.5,"dc:description":"Splice studies show that this variant leads to an in frame deletion and escapes NMD so reduced to 0.1 default. Functional studies so increased to 0.5."},{"id":"cggv:65b3c9c3-aaf5-4fd3-bd5c-af8f39da1abb","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:65b3c9c3-aaf5-4fd3-bd5c-af8f39da1abb_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0f4fa986-9d21-41e0-95fe-8d219e2cc2f4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0f4fa986-9d21-41e0-95fe-8d219e2cc2f4","type":"Proband","ageType":"AgeAtDeath","ageUnit":"WeeksGestation","ageValue":27,"allele":{"id":"cggv:4e840348-fef3-4aea-912b-243787c798e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.1735C>T (p.Gln579Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390660256"}},"sex":"Male","variant":{"id":"cggv:e6d5f1e2-0dba-49da-a173-221350b62058_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:4e840348-fef3-4aea-912b-243787c798e9"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/23956106"},"rdfs:label":"Grigelioniene 2013 Case1"},{"id":"cggv:e6d5f1e2-0dba-49da-a173-221350b62058","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:e6d5f1e2-0dba-49da-a173-221350b62058_variant_evidence_item"}],"strengthScore":1,"dc:description":"Consanguineous"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:dadc1330-7f6d-4c0f-87c3-747bf01b505a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:dadc1330-7f6d-4c0f-87c3-747bf01b505a","type":"Proband","allele":{"id":"cggv:5c9be85d-62b2-4040-ba11-c158947f6dba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.5420G>T (p.Gly1807Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390644509"}},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0003826","obo:HP_0002652"],"secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"cggv:e97e1204-f01f-428e-80aa-1d820becbac8_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:5c9be85d-62b2-4040-ba11-c158947f6dba"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29620724","type":"dc:BibliographicResource","dc:abstract":"To describe our experience with a large cohort (411 patients from 288 families) of various forms of skeletal dysplasia who were molecularly characterized.","dc:creator":"Maddirevula S","dc:date":"2018","dc:title":"Expanding the phenome and variome of skeletal dysplasia."}},"rdfs:label":"Maddirevula 2017 16DG0956"},{"id":"cggv:e97e1204-f01f-428e-80aa-1d820becbac8","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:e97e1204-f01f-428e-80aa-1d820becbac8_variant_evidence_item"}],"strengthScore":0,"dc:description":"Consanguineous with no functional data so not scoring"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a1da7fdc-3254-419a-993f-863896c605da_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a1da7fdc-3254-419a-993f-863896c605da","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":12,"allele":[{"id":"cggv:2467cdcd-d99d-41da-8d97-8159e95d5a46","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.1622del (p.Lys541ArgfsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA487832034"}},{"id":"cggv:e1075cb4-2cde-4073-a280-6713891a13b6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.5416A>G (p.Met1806Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390644523"}}],"phenotypes":["obo:HP_0004322","obo:HP_0000774","obo:HP_0000703","obo:HP_0002650","obo:HP_0001156","obo:HP_0003027","obo:HP_0000113","obo:HP_0002657","obo:HP_0000238","obo:HP_0000256","obo:HP_0000768"],"previousTesting":true,"previousTestingDescription":"FGFR3, COL2A1 Sanger sequencing","sex":"Male","variant":[{"id":"cggv:4170ab48-b8e4-4fdd-afa1-c1c985d869c0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:2467cdcd-d99d-41da-8d97-8159e95d5a46"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"},{"id":"cggv:eb37c10d-b34b-44f9-a3fa-73bb1c8df1af_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e1075cb4-2cde-4073-a280-6713891a13b6"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"}],"rdfs:label":"Wehrle 2019 Case6"},{"id":"cggv:eb37c10d-b34b-44f9-a3fa-73bb1c8df1af","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:eb37c10d-b34b-44f9-a3fa-73bb1c8df1af_variant_evidence_item"},{"id":"cggv:eb37c10d-b34b-44f9-a3fa-73bb1c8df1af_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Splicing studies show that it leads to missplicing, Western blot & immunohistochemistry."}],"strengthScore":0.5},{"id":"cggv:4170ab48-b8e4-4fdd-afa1-c1c985d869c0","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:4170ab48-b8e4-4fdd-afa1-c1c985d869c0_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:d55c62d8-d3b5-43f9-b5d1-4e362f0c7709_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:d55c62d8-d3b5-43f9-b5d1-4e362f0c7709","type":"Proband","allele":{"id":"cggv:cf915b50-0f9e-4712-acfd-313b49bd7fc2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.4205_4206del (p.Gln1402ArgfsTer8)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2626168204"}},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0009826","obo:HP_0002652","obo:HP_0003270"],"secondTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"cggv:c6bfd81b-39a1-4ff1-b5d4-371da95c83bd_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:cf915b50-0f9e-4712-acfd-313b49bd7fc2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29620724"},"rdfs:label":"Maddirevula 2017 15DG1394"},{"id":"cggv:c6bfd81b-39a1-4ff1-b5d4-371da95c83bd","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:c6bfd81b-39a1-4ff1-b5d4-371da95c83bd_variant_evidence_item"}],"strengthScore":1,"dc:description":"Consanguineous"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:2178ce27-e041-4537-9040-f09615cc9933_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2178ce27-e041-4537-9040-f09615cc9933","type":"Proband","allele":{"id":"cggv:e665d505-370f-4b49-9157-58e16f080359","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.763C>T (p.Arg255Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390664677"}},"firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0002652","obo:HP_0005257","obo:HP_0002240"],"secondTestingMethod":"Exome sequencing","sex":"Female","variant":{"id":"cggv:8b23f266-69b2-4de3-b8fe-ed39fc34b632_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e665d505-370f-4b49-9157-58e16f080359"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29620724"},"rdfs:label":"Maddirevula 2017 11DG0205"},{"id":"cggv:8b23f266-69b2-4de3-b8fe-ed39fc34b632","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8b23f266-69b2-4de3-b8fe-ed39fc34b632_variant_evidence_item"}],"strengthScore":1,"dc:description":"Consanguineous"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:cb7b62f9-b04b-454a-bb58-90bd725f8814_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:cb7b62f9-b04b-454a-bb58-90bd725f8814","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"allele":{"id":"cggv:f2ce7f0d-bc38-4a8c-8958-dde8d21ab9d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.1228G>T (p.Asp410Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA390663045"}},"phenotypes":["obo:HP_0002650","obo:HP_0000774","obo:HP_0004322","obo:HP_0003027","obo:HP_0001156","obo:HP_0000703","obo:HP_0002657","obo:HP_0000256"],"sex":"Female","variant":{"id":"cggv:466daf84-d4df-4657-bd24-88291343b9be_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f2ce7f0d-bc38-4a8c-8958-dde8d21ab9d3"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"},"rdfs:label":"Wehrle 2019 Case3"},{"id":"cggv:466daf84-d4df-4657-bd24-88291343b9be","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:466daf84-d4df-4657-bd24-88291343b9be_variant_evidence_item"},{"id":"cggv:466daf84-d4df-4657-bd24-88291343b9be_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Splice studies, Western blotting, immunohistochemistry, "}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:9850021d-8135-48c6-aadf-dbeb953c9de2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:9850021d-8135-48c6-aadf-dbeb953c9de2","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"allele":[{"id":"cggv:919b0bc4-48cb-4f3a-940d-a68104c7e3ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004239.4(TRIP11):c.2128_2129del (p.Ile710CysfsTer19)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913190650"}},{"id":"cggv:f2ce7f0d-bc38-4a8c-8958-dde8d21ab9d3"}],"phenotypes":["obo:HP_0000703","obo:HP_0003027","obo:HP_0002657","obo:HP_0000774","obo:HP_0001156","obo:HP_0004322","obo:HP_0000256"],"sex":"Female","variant":[{"id":"cggv:df85d8b7-9ecc-4989-bfd2-6f5255c5b518_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:919b0bc4-48cb-4f3a-940d-a68104c7e3ba"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"},{"id":"cggv:aafd4557-d1c1-405a-b42d-906515d7db17_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f2ce7f0d-bc38-4a8c-8958-dde8d21ab9d3"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/30728324"}],"rdfs:label":"Wehrle 2019 Case5"},{"id":"cggv:df85d8b7-9ecc-4989-bfd2-6f5255c5b518","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:df85d8b7-9ecc-4989-bfd2-6f5255c5b518_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:aafd4557-d1c1-405a-b42d-906515d7db17","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:aafd4557-d1c1-405a-b42d-906515d7db17_variant_evidence_item"},{"id":"cggv:aafd4557-d1c1-405a-b42d-906515d7db17_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"splice studies, IHC & Western blotting"}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9073,"specifiedBy":"GeneValidityCriteria10","strengthScore":14.5,"subject":{"id":"cggv:0af37425-9034-40ed-826d-46ef9362be57","type":"GeneValidityProposition","disease":"obo:MONDO_1040009","gene":"hgnc:12305","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"TRIP11 (OMIM: 604505) was first reported in relation to autosomal recessive Achondrogensis type 1A (OMIM:200600) in 2010 (Smits et al., PMID: 20089971). Variants in TRIP11 have also been reported in individuals with autosomal recessive Odontochondrodysplasia (OMIM: 184260). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern and phenotypic variability. Some variants have been reported in both Odontochondrodysplasia and Achondrogenesis type 1A cases. Patients with either condition have affected Golgi apparatus. Odontochondrodysplasia is a milder form of Achondrogenesis type 1A with all patients to date being shown to have at least one hypomorphic variant by splicing/functional studies. Although the two condition are clinically distinct, the molecular causes of this difference cannot always be distinguished. Therefore, we decided to curate both these entities together under the term “TRIP11 related skeletal dysplasia”. \nAt least 42 variants (e.g. missense, in-frame indel, nonsense, frameshift, large deletion, complex rearrangement, etc) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. For the purposes of this curation, 16 variants in this gene were scored in the following 4 publications: PMIDs 23956106, 29620724, 29872333 30728324. More variant evidence is available in the literature, but the maximum score for variant evidence (12 pts.) has been reached. This gene-disease association is supported by mouse models (PMID 20089971) and expression studies (PMID 30728324). \nIn summary, there is definitive evidence to support the relationship between TRIP11 and autosomal recessive TRIP11 related skeletal dysplasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Prenatal Expert Panel on the 01/10/2024 (SOP Version 10).","dc:isVersionOf":{"id":"cggv:6867387e-63e6-43f1-83e4-e988db17b661"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}